FDA Grants Traditional Approval to First Complement Inhibitor for Primary IgA Nephropathy
The US FDA has granted traditional approval to Novartis' Fabhalta® (iptacopan), the…
EU Approves First Oral GLP-1 Treatment for Weight Management
The European Commission has approved Wegovy® pill as the EU's first oral…
UAE Strengthens access to innovative care with New Fibrosis Drug Approval
The Emirates Drug Establishment has approved Jascayd® (nerandomilast) for the treatment of…
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B
The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
The FDA has accepted Roche’s supplemental application for Gazyva/Gazyvaro as a treatment…
